Exosomics Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 23
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 8

Exosomics General Information


Developer of biotechnology equipment designed to launch a new generation of tests for cancer screening and liquid biopsy. The company's platform combines their patented approach for isolation of tumor-derived exosomes from blood and urine with state-of-art analytical methods, enabling the patients to get reliable and cost-effective treatments against cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Strada del Petriccio e Belriguardo 35
  • 53100 Siena
  • Italy
+39 0577 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Exosomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 17-May-2017 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2012 Completed Generating Revenue
To view Exosomics’s complete valuation and funding history, request access »

Exosomics Executive Team (1)

Name Title Board Seat Contact Info
Antonio Chiesi MD Founder, Chief Executive Officer and Board Member
To view Exosomics’s complete executive team members history, request access »

Exosomics Board Members (7)

Name Representing Role Since
Anoop Jangi Self Board Member 000 0000
Behzad Mahdavi Ph.D Lonza Group Chairman of the Board 000 0000
Luca Fantuzzi Self Board Member 000 0000
Mario Airoldi MD Self Board Member & Scientific Advisor 000 0000
Mario Piccione Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Exosomics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exosomics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agilent Technologies Corporation Minority 000 0000 000000 0
Biofund Venture Capital Minority 000 0000 000000 0
Black Swan Trade Other Minority 000 0000 000000 0
FinBiotech Other Minority 000 0000 000000 0
HansaBioMed Life Sciences Other Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »